T rachoma remains a leading cause of blindness in many of the world's poorest regions. 1 It is caused by the obligate intracellular bacterium Chlamydia trachomatis, and is characterized by episodes of recurrent, chronic follicular conjunctivitis. In some individuals, this inflammation results in progressive scarring of the tarsal conjunctiva, leading to the blinding complications of trichiasis and corneal opacification.
The control of blinding trachoma focuses on the implementation of the surgery, antibiotics, facial cleanliness, and environmental improvement (SAFE) strategy. 2 Current World Health Organization (WHO) guidelines recommend annual mass drug administration (MDA) with oral azithromycin or topical tetracycline for 3 years to entire communities where the prevalence of trachomatous inflammation-follicular (TF; Simplified WHO Trachoma Grading System 3 ) in children 1 to 9 years of age (TF %1-9 ) is greater than 10%. 2 However, it has been recognized for some time that in low prevalence settings, the relationship between the signs of TF and the detection of C. trachomatis infection is variable and at times very weak. 4 -7 This relationship becomes even less consistent after the introduction of antibiotic control programs. 8 -10 The discordance between disease and chlamydial infection is an increasingly important issue for trachoma control programs as the prevalence of trachoma declines. When deciding to initiate or stop MDA, programs currently have no practical alternative to assessing the prevalence of clinical signs of active trachoma. There are probably several factors that contribute to the mismatch in signs and infection. First, the temporal sequence for these two events differs: infection probably starts and finishes before the inflammatory response, which can persist for many weeks after the resolution of infection. 11 At a population level, the prevalence of TF appears to take very much longer to decline after the initiation of MDA than the prevalence of chlamydial infection. 8 -10 It has been found to stay above the 10% TF treatment threshold for months or years in the absence of detectable chlamydial infection. Second, there are other recognized causes of a follicular conjunctivitis, such as other bacteria and certain viruses. It is plausible that, in an individual who has previously developed a follicular response to C. trachomatis, subsequent nonchlamydial infections causing conjunctival inflammation might be more likely to elicit a follicular reaction that mimics TF.
To investigate the relationship between the signs of TF and C. trachomatis and other bacterial species, we conducted a cross-sectional survey of the children living in a trachomaendemic community, relating the clinical phenotype to laboratory evidence of infection.
METHODS

Ethical Approval
This study adhered to the tenets of the Declaration of Helsinki. It was approved by the Tanzanian National Institute of Medical Research Ethics Committee, the Kilimanjaro Christian Medical Centre Ethics Committee, and the London School of Hygiene and Tropical Medicine Ethics Committee. The study was explained to the parents/guardians of potential study subjects. Informed consent was documented in writing by the parent/guardian on behalf of each child before recruitment.
Study Participants
The study was conducted in a single village in Siha District, Kilimanjaro Region, Northern Tanzania. We carried out a census of the village. All children under 10 years of age who were present and for whom consent was given were enrolled into the study. This district had never received MDA for trachoma control.
Clinical Assessment and Sample Collection
The left eye of each subject was examined by a single ophthalmologist (MJB) using 2.5ϫ loupes and a bright torch. Clinical signs were graded using the 1981 WHO Trachoma Grading System (FPC). 12 Clinically active trachoma was defined as the presence of either a follicular score of 2 or 3 (F2/3) or a papillary score of 3 (P3), equivalent to TF and trachomatous inflammation-intense (TI) of the WHO Simplified Trachoma Grading System, respectively. 3 The conjunctiva was anesthetized with preservative-free proxymetacaine 0.5% eye drops (Minims; Chauvin Pharmaceuticals, Surrey, UK). A rayon-tipped swab sample was collected from the inferior fornix, placed immediately into Amiescharcoal transport media (Sterilin, Caerphilly, UK) and kept at ambient temperature until processing in the laboratory later the same day. A second, Dacron polyester-tipped swab (Hardwood Products Company, Guilford, Maine) was collected from the left upper tarsal conjunctiva for the detection of C. trachomatis in a standardized manner (passed firmly four times across the conjunctiva with a quarter turn between each pass). The samples for PCR were kept on ice packs until transfer to a -80°C freezer later the same day for storage until processing. The examiner changed gloves before examining and collecting swabs from each child. "Negative field controls" were collected after every 50 subjects by passing the swab through the air a few centimeters in front of a seated study subject. The village was mass treated with single dose oral azithromycin immediately after the survey.
Laboratory Tests
Microbiology testing was performed at the KCMC Biotechnology Laboratory, Moshi, Tanzania. Microbiology samples were inoculated onto blood and chocolate agar later the same day (usually Ͻ6 hours from the collection time) and incubated at 37°C for 48 hours. Culture isolates were identified by standard microbiologic techniques. Testing for C. trachomatis by PCR was performed at the MRC Laboratories, Gambia; samples were transferred there on dry ice. DNA was extracted from the dry swab using an isolation kit (QIAmp DNA mini kit; Qiagen, Crawley, UK). C. trachomatis was detected using a test kit (Amplicor CT/NG kit; Roche Molecular Systems, Branchburg, NJ), with previously described modifications.
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Data Analysis
Data were entered into a database (Access 2007; Microsoft, Redmond, WA) and analyzed using software (STATA, v 11.0; StataCorp LP, College Station, TX). A nonparametric test for trend was used to examine the relationship between bacterial culture results and the ordered categories of follicular and papillary inflammation severity.
2 tests were used to determine strength of association for individual bacterial isolates with the TF status, with an exact test used if there were fewer than five expected events in a cell. Odds ratios (ORs) and 95% confidence intervals (CIs) for the univariate associations between TF and each factor were estimated using logistic regression, and P values were estimated using likelihood ratio tests. Factors associated with TF (P Ͻ 0.10) were included in a multivariable logistic regression model. Age was considered an a priori confounder because of the known association with TF. Staphylococcus epidermidis, Corynebacterium spp., viridans group streptococci, and Bacillus spp. were designated as commensal organisms for the purposes of this analysis.
RESULTS
Study Participants and Samples
A total of 700 children under 10 years of age were recorded as living in the study village at the time of this survey. We were able to examine 571 (81.5%) children. Of the 129 children not examined, 58 (45%) had traveled away, 29 (23%) refused, 25 (19%) were too young, and 17 (2%) were not found despite several visits. Bacteriology and C. trachomatis PCR samples were collected from 484 (84.8%) and 557 (97.5%) of the 571 children who were examined, respectively. Both bacteriology and C. trachomatis PCR results were available on a total of 473 of 571 (82.8%) children. Comparing the 473 children for whom results were obtained and all the other 227 children living in the village, there was no difference in either the mean age (P ϭ 0.92) or the proportion who were of male sex (47.6%; P ϭ 0.20). The 98 children who were examined but did not have both microbiology and chlamydial PCR results were slightly older (5.8 vs. 5.0 years; P ϭ 0.01); the proportion that was male was comparable (P ϭ 0.13). All subsequent analyses are limited to the 473 children with both laboratory results.
Clinical Signs and C. trachomatis Infection
TF was diagnosed in 65 (13.7%) children. The frequencies of the FPC Grading System follicular (F) and papillary (P) inflammation scores are shown in Table 1 . C. trachomatis DNA was detected by Amplicor PCR in 25 (5.3%) samples. The frequency of PCR positive samples by clinical grade is shown in Table 1 . There was no association between the presence of TF and the detection of C. trachomatis (OR, 1.21; 95% CI, 0.40 -3.64; P ϭ 0.74). All "negative field controls" tested negative by Amplicor C. trachomatis PCR.
Conjunctival Bacterial Culture
Bacteria were cultured and identified from 305 (64.5%) swab samples, of which 162 (34.3%) grew a pathogen (with or without a commensal organism) and 143 (30.2%) grew commensal bacteria only. A wide range of organisms was cultured (Table 2) . Double infections were found in 107 and triple infection in 20 eyes. Only 11 of these involved combinations of The frequency of C. trachomatis infection for the different follicular (F) and papillary (P) inflammation grades of the FPC system and for the trachomatous inflammation-follicular (TF) and trachomatous inflammation-intense (TI) scores of the Simplified World Health Organization system. * This percentage value is for the number infected within each clinical disease grade. the more common pathogenic organisms. There was no significant difference between the three bacterial infection categories (no growth, commensal only, and pathogen) in the proportion of eyes with C. trachomatis detected (P ϭ 0.21).
Clinical Signs and Bacterial Infection
Pathogenic bacteria were grown from samples from 61.1% of eyes with TF compared to 29.9% of eyes without TF. There was no difference in the proportion of eyes with or without TF that had commensal bacteria (Table 2) . Streptococcus pneumoniae, Haemophilus influenzae type B, and Haemophilus influenzae non-type B were significantly more frequent in eyes with TF (Table 2 ). There was an increasing trend in the proportion of eyes with bacterial pathogens cultured with increasing FPC follicular score (P Ͻ 0.001; Table 3 ). There was a similar but less marked increase for FPC papillary inflammation (Table 3 ). There were also significant univariate associations between TF and being younger than 3 years of age and with having pathogenic bacteria cultured (Table 4) . In a multivariable logistic regression model, S. pneumoniae, H. influenzae type B, and H. influenzae non-type B were all independently associated with TF (Table 5) .
DISCUSSION
In this study, the prevalence of TF %1-9 was relatively low (13.7%) but was still above the 10% treatment threshold for initiating community level MDA. 2 An additional 18% of the children in this population had a mild follicular conjunctivitis (FPC grade F1). The prevalence of C. trachomatis detected by Amplicor PCR was lower (5.3%) than the prevalence of TF. Overall, we found no association between the signs of active trachoma and chlamydial infection in this community. These observations are consistent with findings from other low prevalence settings and illustrate the difficulty control programs face in determining where to invest resources to distribute antibiotic for trachoma control. 6 -9 The weak relationship between the signs of active trachoma and C. trachomatis infection is likely to lead to many communities receiving unnecessary antibiotic treatment. In regions with an initially higher Frequency of bacterial species cultured in all eyes and by presence or absence of trachomatous inflammation-follicular (TF).
* P values are for 2 , comparing the no TF with the TF group. The Fisher's exact test was used when there were fewer than five events in a cell. The frequency of bacterial infection for the different follicular (F) and papillary (P) inflammation grades of the FPC System and for the TF and TI scores of the Simplified WHO system. TF, trachomatous inflammation-follicular; TI, trachomatous inflammation-intense.
prevalence of disease and chlamydial infection, the relationship between the two weakens markedly after the initiation of MDA. 10 To develop rational strategies for managing MDA in low and medium prevalence settings, it is necessary to have a better understanding of the causes of follicular conjunctivitis in trachoma endemic communities. Probably part of the explanation for the discordance between episodes of active disease and C. trachomatis infection is their different time course. 11, 14 Follicles in children can persist for weeks or months after the chlamydial infection is no longer detectable. In low prevalence settings, C. trachomatis infection prevalence is often so low that it is difficult to imagine that this alone is sufficient to sustain a prevalence of TF above the treatment threshold, and other factors may contribute. 7 In this population-based survey, we examined the potential contribution of nonchlamydial bacterial species to the presence of a "TF" phenotype. In contrast to C. trachomatis, nonchlamydial bacteria were frequently cultured from the conjunctiva of children. The range of organisms included some that are generally considered commensal and others normally considered to be pathogens. We found no association between the presence of TF and the presence of a commensal organism alone. However, we did find a clear association between TF and pathogenic bacteria, specifically S. pneumoniae and H. influenzae. There was no significant difference in the frequency of bacterial pathogens between individuals with no follicles (F0) and those with very few follicles, below the diagnostic threshold for TF (F1).
There are little published data on the normal conjunctival bacterial flora in children in Africa. The only recent study comes from a village in Sierra Leone, a country that does not have endemic trachoma, which tested people of all ages. 15 This study found 86% had positive cultures (S. epidermidis 28%, S. aureus 20%, P. aeruginosa 6%, Klebsiella 4%, and H. influenzae 2%). However, there were a number of differences in the range and relative frequencies of organisms cultured in these two studies. For example, the study from West Africa did not identify any S. pneumoniae and only relatively few H. influenzae. These differences could be attributable to differences in sample collection and processing (performed in the United States), population demographics (only 16% under 18 years of age), and the environment (more humid) in the Sierra Leonean study.
A number of studies have investigated bacterial infection in children living in trachoma-endemic regions (Table 6) . 16 -21 However, these were mostly conducted before the development of sensitive PCR-based techniques for C. trachomatis detection and the current trachoma grading systems. 3, 12 In addition, a number of methodologic variations make it difficult to draw definite conclusions about the contribution of other bacteria to follicular conjunctivitis in trachoma-endemic environments. Several studies were not population-based, only including cases with active trachoma or with a limited selection of unaffected individuals. 16, 17, 20 Two studies present microbiology results based on microscopy alone (no culture performed). 18, 20 In these earlier studies, the range of organisms identified by culture was generally similar to those we found, albeit with some differences in the relative frequency. In the most methodologically comparable studies to ours, S. pneumoniae and H. influenzae were prominent among the pathogens. 16, 19, 21 In two studies, it is possible to partially evaluate the relationship between active trachoma and bacterial infection. 16, 17 In the larger of these, reanalysis of the available data suggests a significant association between active trachoma and conjunctival pathogens, when compared to normal healthy controls.
16 Surprisingly, the authors reached the opposite conclusion-that individuals with trachomatous conjunctivitis were no more likely to grow a pathogen than controls. However, in their analysis, they included within the control group a large number of individuals with "simple bacterial conjunctivitis," which added to the number of pathogens identified in the control group and probably should not have been regarded as clinically normal.
We have previously found that individuals with established trichiasis and conjunctival scarring are more likely to have nonchlamydial bacterial infections. [22] [23] [24] This is often associated with a marked clinically apparent inflammatory reaction in the conjunctiva in the absence of detectable C. trachomatis infection. 22 In addition, after trichiasis surgery, individuals with bacterial infection had significantly increased expression of various factors that could plausibly be involved with the scarring process (interleukin-1␤, tumor necrosis factor-␣, and matrix metalloproteinases-1 and -9). 25 This raises the possibility that these other bacteria could contribute to stimulating progressive cicatricial disease in conjunctiva that has previously been damaged by the immune response to C. trachomatis.
This study, from an area with low prevalence trachoma, indicates the potential importance of nonchlamydial bacterial pathogens in the production of a follicular phenotype. The possibility of reverse causality in the association between bacterial pathogens and follicular conjunctivitis (namely, that eyes with TF are more susceptible to being infected with bacteria) cannot be ruled out in a cross-sectional study. However, even if this is part of the explanation for the observed association, it remains probable that these other bacteria contribute to the inflammatory response. It has long been recognized that various viral and bacterial pathogens can cause a follicular conjunctivitis. It is conceivable that these effects are amplified in a trachoma-endemic population: individuals who have previously developed a follicular conjunctivitis in response to C. trachomatis may more readily reform conjunctival follicles when challenged with certain other bacterial species. This may provide part of the explanation why the community prevalence of TF declines more slowly than chlamydial infection after the successful introduction of MDA. 8, 9 A rapid, inexpensive point of care (POC) test would potentially be very useful to control programs, by providing an indication of whether C. trachomatis is no longer endemic in the face of persisting TF, allowing MDA to be stopped at an earlier stage. 26 Unfortunately, because there is not currently a POC test available, control programs have to base the decision of whether to continue treating on the community prevalence of TF. There is probably some potential to refine the treatment algorithm further as more empiric data on the relationship between infection and disease at different prevalence levels becomes available. The focus of this study was the change in bacterial antibiotic sensitivity patterns after azithromycin treatment; no C. trachomatis test data presented; no analysis of bacterial infection in relation to active trachoma
